IRIS
BRUNETTI, ORONZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.312
AS - Asia 1.581
EU - Europa 903
SA - Sud America 410
AF - Africa 72
OC - Oceania 3
AN - Antartide 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.283
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.255
SG - Singapore 646
CN - Cina 329
BR - Brasile 321
SE - Svezia 224
HK - Hong Kong 200
RU - Federazione Russa 159
VN - Vietnam 136
FR - Francia 102
DE - Germania 92
IT - Italia 89
GB - Regno Unito 78
IN - India 62
FI - Finlandia 50
AR - Argentina 38
ID - Indonesia 30
CA - Canada 29
TR - Turchia 27
BE - Belgio 25
BD - Bangladesh 21
ZA - Sudafrica 20
PL - Polonia 17
CI - Costa d'Avorio 15
PK - Pakistan 15
CO - Colombia 14
IQ - Iraq 14
MX - Messico 14
JP - Giappone 12
ES - Italia 11
UA - Ucraina 11
UZ - Uzbekistan 11
EC - Ecuador 10
MA - Marocco 10
VE - Venezuela 10
AE - Emirati Arabi Uniti 9
CZ - Repubblica Ceca 9
MY - Malesia 7
PH - Filippine 7
CL - Cile 6
ET - Etiopia 6
IL - Israele 6
IR - Iran 6
JO - Giordania 6
KE - Kenya 5
PY - Paraguay 5
AT - Austria 4
CH - Svizzera 4
EG - Egitto 4
KR - Corea 4
KZ - Kazakistan 4
NL - Olanda 4
NP - Nepal 4
SA - Arabia Saudita 4
AU - Australia 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
IE - Irlanda 3
JM - Giamaica 3
KW - Kuwait 3
LT - Lituania 3
PS - Palestinian Territory 3
TN - Tunisia 3
AL - Albania 2
AO - Angola 2
AZ - Azerbaigian 2
BH - Bahrain 2
BY - Bielorussia 2
CR - Costa Rica 2
DK - Danimarca 2
KG - Kirghizistan 2
LB - Libano 2
MM - Myanmar 2
MU - Mauritius 2
QA - Qatar 2
RS - Serbia 2
SV - El Salvador 2
UY - Uruguay 2
AQ - Antartide 1
BB - Barbados 1
BG - Bulgaria 1
BJ - Benin 1
DZ - Algeria 1
GE - Georgia 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MD - Moldavia 1
MT - Malta 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
RO - Romania 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SO - Somalia 1
TG - Togo 1
Totale 7.281
Salva come PNG Salva come JPEG
Città #
Fairfield 519
Ashburn 511
Chandler 443
Singapore 370
Woodbridge 282
Seattle 251
Cambridge 220
Houston 213
Hong Kong 196
Nyköping 182
San Jose 173
Wilmington 170
Beijing 110
Ann Arbor 108
Dearborn 103
Dallas 73
New York 68
Lawrence 57
Roxbury 55
Lauterbourg 51
Los Angeles 51
Council Bluffs 46
Ho Chi Minh City 42
Munich 41
Brooklyn 39
Des Moines 36
São Paulo 32
The Dalles 30
Nanjing 29
Boardman 27
Helsinki 26
Santa Clara 26
San Diego 25
Brussels 24
Dong Ket 24
Moscow 24
Columbus 22
Hanoi 22
Jakarta 22
Bari 19
Turku 19
Paris 17
Frankfurt am Main 16
Abidjan 15
Inglewood 15
Chennai 14
Hefei 14
Montreal 14
Pune 13
Warsaw 13
Da Nang 12
London 12
Orem 12
Phoenix 12
Tokyo 12
Chicago 11
Denver 11
Marseille 11
Buffalo 10
Shanghai 10
Johannesburg 9
Stockholm 9
Tashkent 9
Belo Horizonte 8
Guangzhou 8
Jinan 8
Lahore 8
Manchester 8
Poplar 8
Rio de Janeiro 8
San Francisco 8
San Mateo 8
Atlanta 7
Düsseldorf 7
Mumbai 7
Nuremberg 7
Amman 6
Augusta 6
Brno 6
Campinas 6
Curitiba 6
Dhaka 6
Edinburgh 6
Jacksonville 6
Addis Ababa 5
Baghdad 5
Blumenau 5
Kilburn 5
Kunming 5
Monmouth Junction 5
Princeton 5
Salvador 5
Toronto 5
Washington 5
Zhengzhou 5
Ankara 4
Ardabil 4
Asunción 4
Goiânia 4
Istanbul 4
Totale 5.275
Salva come PNG Salva come JPEG
Nome #
Mast cells and angiogenesis in pancreatic ductal adenocarcinoma 246
Angiogenesis in adenosquamous cancer of pancreas 217
Angiogenesis in pancreatic ductal adenocarcinoma: A controversial issue 188
Emerging role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma 177
CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer 176
Fisiologia V Ed. 174
Bone metastasis as primary presentation of pancreatic ductal adenocarcinoma: A case report and literature review 171
Everolimus restrains the paracrine pro-osteoclast activity of breast cancer cells 167
Targeting angiogenesis in biliary tract cancers: An open option 165
Inflammatory cells infiltrate and angiogenesis in locally advanced and metastatic cholangiocarcinoma 165
Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical Overview 161
Antiangiogenic agents after first line and sorafenib plus chemoembolization: A systematic review 155
Neoadjuvant multimodal treatment of pancreatic ductal adenocarcinoma 155
Multicenter prospective study of angiogenesis polymorphism validation in HCC patients treated with sorafenib. An INNOVATE study protocol 154
Bone metastases in biliary cancers: A multicenter retrospective survey 154
Effects of metformin on clinical outcome in diabetic patients with advanced HCC receiving sorafenib 149
Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma 149
Systematic review of irreversible electroporation role in management of locally advanced pancreatic cancer 149
Strategies to improve cancer immune checkpoint inhibitors efficacy, other than abscopal effect: A systematic review 149
Potential predictive role of chemotherapy-induced changes of soluble CD40 ligand in untreated advanced pancreatic ductal adenocarcinoma 147
Role of miR-27a, miR-181a and miR-20b in gastric cancer hypoxia-induced chemoresistance 140
Metronomic capecitabine versus best supportive care as second-line treatment in hepatocellular carcinoma: A retrospective study 137
Micro-RNA in pancreatic adenocarcinoma: Predictive/prognostic biomarkers or therapeutic targets? 137
Multimodal treatment of resectable pancreatic ductal adenocarcinoma 135
Long‐term survival of an advanced colorectal cancer patient treated with Regorafenib: Case report and literature review 132
Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib 131
The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy 131
Validation of a Simple Scoring System to Predict Sorafenib Effectiveness in Patients with Hepatocellular Carcinoma 130
Systemic chemotherapy for advanced rare pancreatic histotype tumors: A retrospective multicenter analysis 126
Immunotherapy for colorectal cancer: where are we heading? 122
Molecular characterization of a long-term survivor double metastatic non-small cell lung cancer and pancreatic ductal adenocarcinoma treated with gefitinib in combination with gemcitabine plus nab-paclitaxel and mFOLFOX6 as first and second line therapy 121
Combination of Ipilimumab and Nivolumab in Cancers: From Clinical Practice to Ongoing Clinical Trials 120
Cytotoxic t-lymphocyte antigen-4 in colorectal cancer: Another therapeutic side of capecitabine 120
Second-line chemotherapy for advanced pancreatic cancer: Which is the best option? 116
The potential predictive role of nuclear NHERF1 expression in advanced gastric cancer patients treated with epirubicin/oxaliplatin/capecitabine first line chemotherapy 114
Bone metastases in hepatocellular carcinoma: an emerging issue 113
The Immune Revolution in Gastrointestinal Tumours: Leading the Way or Just Following? 112
Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors 109
COVID-19 Infection in Cancer Patients: How Can Oncologists Deal With These Patients? 108
Management of patients with end-stage renal disease undergoing chemotherapy: Recommendations of the Associazione Italiana di Oncologia Medica (AIOM) and the Società Italiana di Nefrologia (SIN) 108
Immunological mutational signature in adenosquamous cancer of pancreas: an exploratory study of potentially therapeutic targets 100
Expression and characterization of a novel recombinant cytotoxin II from Naja naja oxiana venom: A potential treatment for breast cancer 100
Basics and frontiers on pancreatic cancer for radiation oncology: Target delineation, SBRT, SIB technique, MRgRT, particle therapy, immunotherapy and clinical guidelines 98
Clinical practice guidelines for diagnosis, treatment and follow-up of exocrine pancreatic ductal adenocarcinoma: Evidence evaluation and recommendations by the italian association of medical oncology (AIOM) 97
Prediction of survival with second-line therapy in biliary tract cancer: Actualisation of the AGEO CT2BIL cohort and European multicentre validations 96
Somatic BRCA Mutation in a Cholangiocarcinoma Patient for HBOC Syndrome Detection 93
Complete Response of Synchronous Liver Metastasis in a Pancreatic Ductal Adenocarcinoma: Could Surgery Represent a Therapeutic Option? 89
A scoping review on the potentiality of PD-L1-inhibiting microRNAs in treating colorectal cancer: Toward single-cell sequencing-guided biocompatible-based delivery 89
Immune system and bone microenvironment: rationale for targeted cancer therapies 88
Paraneoplastic focal segmental glomerulosclerosis in sarcomatoid renal cell cancer. 88
null 81
The latest findings of PD-1/PD-L1 inhibitor application in gynecologic cancers 76
NLRP3 Inflammasome From Bench to Bedside: New Perspectives for Triple Negative Breast Cancer 76
Role of BRAF in Hepatocellular Carcinoma: A Rationale for Future Targeted Cancer Therapies 74
null 67
null 61
Second-line treatments for Advanced Hepatocellular Carcinoma: A Systematic Review and Bayesian Network Meta-analysis 57
Is it Time for a Therapeutic Algorithm in Resected Pancreatic Ductal Adenocarcinoma? 51
On the Management of Drug Interactions in the Course of Concomitant Treatments for COVID-19 and Antineoplastic Agents 50
Hepatocellular carcinoma treatment over sorafenib: epigenetics, microRNAs and microenvironment. Is there a light at the end of the tunnel? 49
Moving the target on the optimal adjuvant strategy for resected pancreatic cancers: A systematic review with meta-analysis 49
The Role of V-Domain Ig Suppressor of T Cell Activation (VISTA) in Cancer Therapy: Lessons Learned and the Road Ahead 45
Identification of Common and Distinct Pathways in Inflammatory Bowel Disease and Colorectal Cancer: A Hypothesis Based on Weighted Gene Co-Expression Network Analysis 12
Totale 7.516
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.355
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.355
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021227 0 0 0 0 0 0 0 0 0 87 75 65
2021/2022509 42 19 13 15 20 45 17 30 37 46 68 157
2022/2023929 104 155 85 75 85 95 15 113 140 5 40 17
2023/2024324 19 59 15 28 33 95 7 9 3 7 3 46
2024/20251.210 53 11 85 51 47 111 103 107 44 79 197 322
2025/20262.229 405 115 168 281 326 124 258 80 272 200 0 0
Totale 7.516